Ambu A/S (OTCMKTS:AMBBY) Announces Quarterly Earnings Results

Ambu A/S (OTCMKTS:AMBBY) issued its earnings results on Thursday. The company reported $0.10 earnings per share (EPS) for the quarter, Zacks reports. Ambu A/S had a net margin of 4.30% and a return on equity of 4.11%.

Ambu A/S Price Performance

Shares of Ambu A/S stock opened at $19.01 on Friday. The company has a market cap of $4.47 billion and a price-to-earnings ratio of 158.38. Ambu A/S has a twelve month low of $13.02 and a twelve month high of $22.65. The company has a quick ratio of 1.47, a current ratio of 2.49 and a debt-to-equity ratio of 0.09. The company’s 50 day moving average is $15.81 and its 200 day moving average is $18.09.

Ambu A/S Announces Dividend

The firm also recently declared a dividend, which was paid on Monday, December 23rd. Stockholders of record on Friday, December 6th were issued a dividend of $0.0557 per share. The ex-dividend date of this dividend was Friday, December 6th. Ambu A/S’s payout ratio is currently 25.00%.

Ambu A/S Company Profile

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.